{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:27:28Z","timestamp":1780406848166,"version":"3.54.1"},"reference-count":31,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The management of Mycoplasma genitalium sexually transmitted infection (STI) is hindered by increasing resistance to the recommended antibiotics, macrolides and quinolones, worldwide. In Gipuzkoa (Basque Country, Spain), macrolide and quinolone resistance rates in 2014\u20132018 were reported as &lt;20% and &lt;10%, respectively. The aims of this study were to compare these rates with those in 2019\u20132021 and analyse the genetic and epidemiological features of the strains and cases associated with striking changes in the resistance trends. Resistance to macrolides (n = 1019) and quinolones (n = 958) was studied, analysing mutations in 23S rRNA and parC\/gyrA genes, respectively. The rate of macrolide resistance increased from 17.3% in 2014\u20132018 to 32.1% in 2019\u20132021, as much in the more prevalent A2058\/2059G mutations (16.6\u201327.8%) as in the emergent A2058T mutations (0.5\u20134.1%) but with differences in the odds ratios and the relative risk increase between A2058T and A2058\/2059G mutations. MG191 adhesin and MG309 lipoprotein of the 27 emergent strains detected with A2058T mutations were amplified, sequenced, and typed using phylogenetic and variable number tandem repeat analysis, respectively. Genetic clonal spread was ruled out, but most of the A2058T cases were men who had sex with men (24\/27) with a history of STI and antibiotic treatments (19\/27). No changes were observed in quinolone resistance trends, but the rate of resistance to both antibiotics rose from 2.9% to 8.3%, especially in cases with A2058T mutations. The genetic characterisation of strains and epidemiological surveillance of cases are needed to detect populations at increased risk of treatment failure in this infection.<\/jats:p>","DOI":"10.3390\/antibiotics11111492","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T20:37:58Z","timestamp":1666903078000},"page":"1492","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Increases in the Macrolide Resistance of Mycoplasma genitalium and the Emergence of the A2058T Mutation in the 23S rRNA Gene: Clonal Spread?"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-5557","authenticated-orcid":false,"given":"Luis","family":"Pi\u00f1eiro","sequence":"first","affiliation":[{"name":"Microbiology Department, Donostia University Hospital, 20014 Donostia, Spain"},{"name":"Biodonostia Health Research Institute, 20014 Donostia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Idigoras","sequence":"additional","affiliation":[{"name":"Microbiology Department, Donostia University Hospital, 20014 Donostia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitane","family":"Arrastia","sequence":"additional","affiliation":[{"name":"Microbiology Department, Donostia University Hospital, 20014 Donostia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6628-8305","authenticated-orcid":false,"given":"Ayla","family":"Manzanal","sequence":"additional","affiliation":[{"name":"Microbiology Department, Donostia University Hospital, 20014 Donostia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-6435","authenticated-orcid":false,"given":"I\u00f1igo","family":"Ansa","sequence":"additional","affiliation":[{"name":"Microbiology Department, Donostia University Hospital, 20014 Donostia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Cilla","sequence":"additional","affiliation":[{"name":"Microbiology Department, Donostia University Hospital, 20014 Donostia, Spain"},{"name":"Biodonostia Health Research Institute, 20014 Donostia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jdv.17972","article-title":"2021 European guideline on the management of Mycoplasma genitalium infections","volume":"36","author":"Jensen","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/JCM.00370-17","article-title":"High Macrolide Resistance in Mycoplasma genitalium Strains Causing Infection in Auckland, New Zealand","volume":"55","author":"Basu","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/sextrans-2017-053480","article-title":"Mycoplasma genitalium: High prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney","volume":"94","author":"Couldwell","year":"2018","journal-title":"Sex. Transm. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3201\/eid2504.181258","article-title":"Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men","volume":"25","author":"Read","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: A systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10096-020-04061-w","article-title":"Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands","volume":"40","author":"Nijhuis","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_7","unstructured":"(2022, July 15). Australian STI Management Guidelines. Available online: http:\/\/www.sti.guidelines.org.au\/sexually-transmissible-infections\/mycoplasma-genitalium#diagnosis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Murray, G.L., Bodiyabadu, K., Vodstrcil, L.A., Machalek, D.A., Danielewski, J., Plummer, E.L., Garland, S.M., Whiley, D.M., Sweeney, E.L., and Bradshaw, C.S. (2022). parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure. Antimicrob. Agents Chemother., 66.","DOI":"10.1128\/aac.00278-22"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S1473-3099(21)00629-0","article-title":"Individualised treatment of Mycoplasma genitalium infection-incorporation of fluoroquinolone resistance testing into clinical care","volume":"22","author":"Sweeney","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/cid\/ciab1058","article-title":"Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure","volume":"75","author":"Vodstrcil","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","first-page":"394","article-title":"Guided antibiotic therapy for Mycoplasma genitalium infections: Analysis of mutations associated with resistance to macrolides and fluoroquinolones","volume":"37","author":"Idigoras","year":"2019","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pi\u00f1eiro, L., Idigoras, P., and Cilla, G. (2019). Molecular Typing of Mycoplasma genitalium-Positive Specimens Discriminates between Persistent and Recurrent Infections in Cases of Treatment Failure and Supports Contact Tracing. Microorganisms, 7.","DOI":"10.3390\/microorganisms7120609"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/JCM.03318-13","article-title":"Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis","volume":"52","author":"Touati","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance","volume":"36","author":"Shimada","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1128\/JCM.00495-13","article-title":"Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium","volume":"51","author":"Tagg","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/JCM.41.1.261-266.2003","article-title":"Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene","volume":"41","author":"Jensen","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/JCM.42.10.4876-4878.2004","article-title":"Single-nucleotide polymorphisms in the rRNA operon and variable numbers of tandem repeats in the lipoprotein gene among Mycoplasma genitalium strains from clinical specimens","volume":"42","author":"Ma","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1093\/infdis\/jix132","article-title":"New Horizons in Mycoplasma genitalium Treatment","volume":"216","author":"Bradshaw","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Van der Schalk, T.E., Braam, J.F., and Kusters, J.G. (2020). Molecular basis of antimicrobial resistance in Mycoplasma genitalium. Int. J. Antimicrob. Agents, 55.","DOI":"10.1016\/j.ijantimicag.2020.105911"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/OLQ.0000000000000631","article-title":"Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain","volume":"44","author":"Jensen","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","article-title":"Macrolide resistance conferred by base substitutions in 23S rRNA","volume":"45","author":"Vester","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sextrans-2019-054129","article-title":"Antimicrobial resistance in Mycoplasma genitalium sampled from the British general population","volume":"96","author":"Pitt","year":"2020","journal-title":"Sex. Transm. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chua, T.P., Bodiyabadu, K., Machalek, D.A., Garland, S.M., Bradshaw, C.S., Plummer, E.L., Danielewski, J., Vodstrcil, L.A., Doyle, M.L., and Murray, G.L. (2021). Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men. J. Med. Microbiol., 70.","DOI":"10.1099\/jmm.0.001429"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1086\/593188","article-title":"Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance","volume":"47","author":"Jensen","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/jac\/dkv246","article-title":"Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women","volume":"70","author":"Falk","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.eimc.2019.06.008","article-title":"Mycoplasma genitalium macrolide resistance update: Rate among a 2016\u20132017 cohort of patients in Barcelona, Spain","volume":"38","author":"Vall","year":"2020","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jac\/dkv136","article-title":"High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment","volume":"70","author":"Nijhuis","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jac\/dkw584","article-title":"High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands","volume":"72","author":"Braam","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/JCM.00003-06","article-title":"Sequence-based typing of Mycoplasma genitalium reveals sexual transmission","volume":"44","author":"Hjorth","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dumke, R. (2022). Molecular Tools for Typing Mycoplasma pneumoniae and Mycoplasma genitalium. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.904494"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/11\/1492\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:04:27Z","timestamp":1760144667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/11\/1492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["antibiotics11111492"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11111492","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}